Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Filings indexed 809 across all filing types
Latest filing 2026-04-07 Governance Information
Country IT Italy
Listing XMIL DIA

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Operating procedures for registration in the list of shareholders in the special list to obtain increased voting rights
Governance Information Classification · 90% confidence The document is a detailed operational procedure describing how shareholders can register for increased voting rights under specific Articles of Association and applicable regulations. It is not announcing meeting results or financial figures, nor is it a request for votes (proxy) or a report. Instead, it lays out internal governance rules and processes regarding shareholder voting rights, which aligns with the Governance Information category.
2026-04-07 English
Modalità operative per l'iscrizione nell'elenco speciale per l'ottenimento della maggiorazione del voto (7 aprile 2026)
Governance Information Classification · 85% confidence The document is an operational guideline issued by Diasorin outlining statutory provisions (articles 9-bis, 9-ter, 9-quater of the Articles of Association and art. 127-quinquies of the TUF) and detailed procedures for shareholders to register in the Special List to obtain enhanced voting rights. It is neither an AGM material, vote result announcement, nor a financial report, but rather a governance-related communication explaining internal rules and governance processes regarding shareholder voting rights. This aligns with the “Governance Information” category (CGR).
2026-04-07 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a press release disclosing the total amount of voting rights pursuant to Consob Regulation article 85-bis. It provides updated numbers of shares and voting rights and references the Special List on the company’s website. This is not a shareholder meeting result but a statutory voting rights announcement under Italian regulation. It fits the Declaration of Voting Results & Voting Rights Announcements category.
2026-04-07 English
Comunicazione dell'ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a press release (‘Comunicato Stampa’) disclosing the total number of voting rights under art. 85-bis of CONSOB Reg. 11971/1999. It is not AGM minutes or vote results, but a regulatory ‘voting rights announcement’. This matches the ‘Declaration of Voting Results & Voting Rights Announcements’ category (DVA).
2026-04-07 Italian
Report on the treasury shares buy-back plan of Diasorin S.p.A. – Period 30/3/2026 – 2/4/2026
Regulatory Filings
2026-04-03 Italian
Informativa sul programma di acquisto di azioni proprie di Diasorin S.p.A. - Periodo 30/3/2026 – 2/4/2026
Regulatory Filings
2026-04-03 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.